Lake Street Advisors Group LLC Buys 221 Shares of Colgate-Palmolive (NYSE:CL)

Lake Street Advisors Group LLC increased its position in Colgate-Palmolive (NYSE:CL) by 4.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,216 shares of the company’s stock after purchasing an additional 221 shares during the quarter. Lake Street Advisors Group LLC’s holdings in Colgate-Palmolive were worth $474,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of CL. D Orazio & Associates Inc. increased its stake in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after buying an additional 108 shares during the period. Fiducient Advisors LLC grew its holdings in Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after acquiring an additional 110 shares in the last quarter. Commonwealth Financial Services LLC increased its position in Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after purchasing an additional 118 shares during the period. Lantz Financial LLC raised its holdings in shares of Colgate-Palmolive by 0.6% in the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after purchasing an additional 122 shares in the last quarter. Finally, Horizon Kinetics Asset Management LLC lifted its position in shares of Colgate-Palmolive by 4.2% in the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock worth $322,000 after purchasing an additional 124 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.1 %

Colgate-Palmolive stock opened at $90.23 on Friday. The firm has a market cap of $73.22 billion, a PE ratio of 25.63, a P/E/G ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The stock’s 50 day simple moving average is $88.75 and its two-hundred day simple moving average is $95.58. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business posted $0.87 earnings per share. Analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CL shares. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. UBS Group reduced their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Finally, Barclays lowered their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.